BioSpace News Archive

VIVOLTA, a world leader in the development and manufacturing of electrospun medical products, announced that it has raised €7M in a new funding round with participation from existing shareholders and the Dutch government’s NXTGEN HIGHTECH growth fund.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, announced that Dankook University Hospital in Cheonan, South Korea, is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform.

Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has acquired a new CNC machining center to increase the production capacity of RemeOs™ products at its factory in Tampere, Finland.

NKGen Biotech Inc. announced that they have been invited to give an oral presentation at the 2nd International Alzheimer’s Disease & Dementia Conference 2023 to be held virtually and in-person in Rome, Italy, from June 16–17, 2023.

Jasper Therapeutics, Inc. announced the appointment of Dr. Edwin J. Tucker as Jasper’s Chief Medical Officer.

Candel Therapeutics, Inc. announced that, in the second quarter of 2024, it expects to report topline overall survival data from its ongoing, open-label, phase 2 clinical trial of CAN-2409 plus valacyclovir in combination with continued immune checkpoint inhibitor treatment in patients with non-resectable, stage III/IV non-small cell lung cancer who progressed while on treatment with PD-1 inhibitor therapy.

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company, announced an initiative, Proactively Recognizing Occurrence in Blood through Education housed on PROBEinCTCL.com which was developed to educate HCPs on the importance of assessing blood involvement in Sézary Syndrome and Mycosis Fungoides—two subtypes of cutaneous T-cell lymphoma.

Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced that it has acquired The Kinetix Group, also known as TKG.

PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC.

SELLAS Life Sciences Group, Inc. announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, has been invited to participate in a fireside chat at the Maxim Group Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, taking place June 20-22, 2023.